Podcasts and Webcasts
Cell Therapies: from Concept to Reality
Samer Kaba, MD
Vice-President, Medical Affairs
QT Evaluation in Early Clinical Development
Thomas Todaro, MD, JD, FACC
Medpace Vice President, Medical Affairs
CRO's - Focus on Laboratories
Rob Danziger
Medpace Reference Laboratories (MRL)
A Partnering Success Story: The model, best practices, benefits, and the story
Debbie Elliott
Director of Clinical Operations
Measuring Disease Progression in Neurology Trials
Samer Kaba, MD
Medical Director
Importance of Vendor Setup and Synchronization at the Start of the Trial
Jennifer Haggard
Director, Clinical Operations
Drug Development in Alzheimer’s Disease - Challenges and Opportunities
Samer Kaba, MD
Medical Director
Drug Development in Alzheimer’s Disease - transcription
Maximizing the Effectiveness of the Partnership with your CRO
Alita Hassan, MPH, BS
Director, Proposal Writing
Maximizing the Effectiveness of the Partnership with your CRO - transcription
Conducting Strategic Clinical Trials in China
Jim Wei, MD, PhD
Executive Director, Medpace Clinical Pharmacology
Conducting Strategic Clinical Trials in China - transcription
Safety and Regulatory Aspects of Obesity Drugs
Dr. David G. Orloff talks to Applied Clinical Trials about the current and potential future regulatory issues for obesity and diabetes drugs, how FDA and industry is moving toward levels of safety for these drug classes.
New FDA Guidelines for Diabetes: Cardiovascular Risk Assessment
David G. Orloff, MD
Executive Director, Medpace Regulatory Affairs
Medpace Bioanalytical in Drug Development
Dr. Yong-Xi Li
Executive Director, Medpace Bioanalytical Laboratories
Medpace Bioanalytical in Drug Development - transcription
Proof-of-Concept Studies and the End of Phase IIa Meeting with the FDA
Jim Wei, MD, PhD
Executive Director, Medpace Clinical Pharmacology
Proof-of-Concept Studies and the End of Phase IIa Meeting with the FDA - transcription
Corporate Videos
Medpace Bioanalytical Laboratories
Medpace Clinical Pharmacology
Medpace Reference Laboratories
Case Studies
Bringing Complex, Concurrent Trials to a
Successful Completion Requires Tremendous Balance
Accelerating patient recruitment demands advance
strategic planning – seamless integration of trial start-up and patient recruitment functions – which
contributes to early patient recruitment
Navigating a Sponsor’s NDA through
a maze of regulatory requirements requires strategic partners who can provide regulatory
collaboration to complete the journey in record time
Recruiting Specialized Patients for Phase I Projects
Project Rescue: The Sponsor initially chose a larger CRO for their drug
development needs. But something was missing.
Pivotal Phase III global study that randomized 250 patients over 51 global sites
to study a lipid altering therapy was completed in record time.
White Papers
Emerging Markets: Climate Change in Latin America Makes for Successful Clinical Trials
Emerging Markets: Navigating the Path to Conduct Successful Clinical Trials in China
Closer Look Interview with Dr. David Orloff - FDA Guidelines on Cardiovascular Risk Assessment
Articles
Heart Hope: Dr. Thomas Todaro talks to Future Pharmaceuticals about the global perspectives in acute coronary syndrome (ACS)
trial conduct and recruitment.
Download article